Inventiva is currently owned by Sofinnova Partners, through Sofinnova Crossover Fund I, since 2019.

When did Sofinnova Partners acquire Inventiva?

Sofinnova Partners acquired Inventiva in 2019 (active for 7 years).

Inventiva

Biotech·

France·Active·7yr hold

Inventiva is a healthcare company, headquartered in France.

Entry

2019

Hold

7yr

Status

Active

Est. EV

–

Most recent investor

2 ownership periods

HQFrance

SectorHealthcare

French clinical-stage company developing oral small molecule drugs for NASH, MPS and other diseases driven by metabolic dysfunction.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

6 portfolio peers in Sofinnova Crossover Fund I

6 comparable biotech deals from other GPs

Already a member? Sign in

Data refreshed weekly · Sourced from public filings